Both in Biotechnology
Allogene Therapeutics vs Fennec Pharmaceuticals
Over the past year ALLO returned −7.6% and FENC returned +29.6%; their daily moves had a correlation of 0.18.
ALLO −7.6% FENC +29.6%Growth of $1, one year, split-adjusted
| Metric | ALLO | FENC |
|---|---|---|
| Price | $1.09 | $10.54 |
| Market cap | $376.6M | $369.6M |
| Today | −7.63% | +2.93% |
| 1 month | −27.3% | +3.3% |
| 6 months | −51.8% | +58.5% |
| Year to date | −20.4% | +36.9% |
| 1 year | −9.9% | +26.5% |
| Revenue growth (YoY) | — | +85.2% |
| Gross margin | 100.0% | 96.0% |
| Net margin | −919.8% | 11.0% |
| P/E (TTM) | — | — |
| Price / sales | 81.2× | 6.2× |
| Net cash | $332.6M | $41.2M |
| Dividend yield | — | — |
| Volatility (60d) | 55.0% | 56.2% |
| Short % of float | 19.4% | 2.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).